Is the pain killer consumption after gingival treatment related to the level of patient anxiety or to the type of therapy?

Anxiety and depression (HAD) scale used could be reveal the level of the patient anxiety and/or depression before intervention.

Additionnaly the use of these specific questionnaires (7 items for anxiety, 7 items for depression) could reveal if the pain killer consumption after gingical treatment is dependant to the level of HAD or to the therapy .

This tool (HAD) could allows to recognize, before any (oral)surgery, profil with high risk and propose solution to decrease anxiety and/or depression before treatment.

Inclusion Criteria:

• ASA type I and II subjects
• Localized Gingival Recessions
• Recessions Cairo RT I-II
• FMPS < 10%
• FMBS< 10%
• <10 cigs/ day
• No contra-indication against oral surgical interventions
• Patient is able to give inform consent

Exclusion Criteria:

• Infection (local or systemic). Each infection will be evaluated prior to study procedure for suitability. Patients with gingivitis or local infection (fracture, apical reaction) will undergo a dental treatment prior to his entrance to the study. In case of systemic infection, the evaluation will be based on medical anamneses, and if necessary will be referred to relevant medical tests.
• ASA type > II
• Current pregnancy or breastfeeding women
• Alcoholism or chronically drug abuse
• Smokers, ≳ 10 cigarettes per day
• Immunocompromised patients
• Uncontrolled diabetes
• Untreated periodontitis
• History of previous periodontal surgery (mucogingival or other) on the teeth to be included
• Presence of severe tooth malposition, rotation or significant version of the tooth to be treated